Literature DB >> 6637313

A comparative study on the analgesic effects of indomethacin and hydromorphinechloride-atropine in acute, ureteral-stone pain.

P Udén, L Rentzhog, T Berger.   

Abstract

In a prospective study, including fifty consecutive patients with acute ureteral-stone pain, the patients were randomly distributed into two groups for treatment. There were given either an intravenous injection of indomethacin (Confortid) 50 mg, or a subcutaneous injection of 2 mg hydromorphine chloride-atropine (Dilaudid-atropin 1 ml). Patients in the latter group also received a suppository of prochlorperazine (Stemetil) 25 mg. The analgesic effect of the two drugs did not differ significantly. Indomethacin was quicker acting, probably due to the intravenous route of administration. The side effects were alike but those caused by indomethacin had a tendency to be milder and of shorter duration.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6637313

Source DB:  PubMed          Journal:  Acta Chir Scand        ISSN: 0001-5482


  5 in total

Review 1.  Nonsteroidal anti-inflammatory drugs (NSAIDs) versus opioids for acute renal colic.

Authors:  A Holdgate; T Pollock
Journal:  Cochrane Database Syst Rev       Date:  2005-04-18

2.  The effect of diclofenac sodium and papaverine on isolated human ureteric smooth muscle.

Authors:  Abdullah Sivrikaya; Omer Fatih Celik; Nursel Sivrikaya; Guner Kemal Ozgur
Journal:  Int Urol Nephrol       Date:  2003       Impact factor: 2.370

Review 3.  Systematic review of the relative efficacy of non-steroidal anti-inflammatory drugs and opioids in the treatment of acute renal colic.

Authors:  Anna Holdgate; Tamara Pollock
Journal:  BMJ       Date:  2004-06-03

4.  [Pain therapy in acute renal colic.].

Authors:  C Tschuschke; S C Müller; L Hertle
Journal:  Schmerz       Date:  1993-09       Impact factor: 1.107

5.  Intramuscular Etofenamate versus Diclofenac in the Relief of Renal Colic : A Randomised, Single-Blind, Comparative Study.

Authors:  Avelino Fraga; Martinho de Almeida; Vítor Moreira-da-Silva; Manuel Sousa-Marques; Luís Severo; Alberto Matos-Ferreira; Luís Campos-Pinheiro; Mário Reis; Ulisses Ribau; Pedro Silveira; Luís Almeida
Journal:  Clin Drug Investig       Date:  2003       Impact factor: 2.859

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.